Andrei Sauko/iStock via Getty Images
- As part of the latest release of its ultrasound systems EPIQ Elite and Affiniti, Royal Philips (NYSE:PHG) announced that the FDA granted 510(k) clearance for the company’s Liver Fat Quantification tools.
- Quantification of liver fat helps physicians in the diagnosis of liver diseases such as non-alcoholic fatty liver disease (NAFLD).
- "With a quantitative way of measuring liver fat, it is a lot easier for us to let the referring physician know where the patient is quantitatively on the NAFLD spectrum,” remarked radiology consultant Richard G. Barr, a Medical Director at Southwoods Imaging.
The company intends to unveil its Liver Fat Quantification solution later this month at the Radiological Society of North America (RSNA) Annual Meeting.
- Philips (PHG) shares sank on Monday amid reports of deepening regulatory scrutiny over the company’s recalled respiratory care devices. However, ResMed (NYSE:RMD), a rival manufacturer of ventilators gained.